Cerebral Therapeutics

AURORA, CO · Biotech · Defunct

Direct-to-brain drug delivery platform for neurological diseases

Claim this profile

Follows are private to you and power your alerts

Updated · cerebraltherapeutics.com

Sector
Biotech
Headquarters
AURORA, CO
Latest Form D
$20M, Jan 2020
Total capital
$22.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$22.5M
2 Form D · last Jan 2020
81 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
29 pending · first 2022
Rank in peer group#46 of 342

Capital timeline

201820192020FEDERAL ↑EQUITY ↓Cumulative $22.5M1st Form D$2.5M2nd Form D$20M
201820192020FEDERAL ↑EQUITY ↓Cumulative $22.5M1st Form D$2.5M2nd Form D$20M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$20M
  • Private capital raisedForm D · SEC · 1st filing$2.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 342 peers

Line = median

Biotech · Platform

  • Granted patents#46 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Daniel AbramsResearcherExecutive Officer, DirectorLinked by 2 patents
  • Mahendra ShahDirectorNamed in SEC Form D filings
  • Matthew HammondDirectorNamed in SEC Form D filings
  • Shah MahendraDirectorNamed in SEC Form D filings
  • Stephen FarrDirectorNamed in SEC Form D filings
  • Warren LammertDirectorNamed in SEC Form D filings
Show all 7 people
  • Weston NicholsDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 32
Show all 32 patent records
  • Medical Device Having Non-filtered Csf Withdrawal PathwayJul 9, 2024 · US 12,029,870Granted
  • Implantable Intraventricular Sampling And Infusion Access DeviceNov 29, 2022 · US 11,511,035Granted
  • High Concentration Medicant Solutions For Treating Neurological DisordersSep 6, 2022 · US 11,433,038Granted
  • Direct Brain Administration Of Chemotherapeutics To The Csf For Patients With Primary And Secondary Brain TumorsMay 28, 2020 · Application 16329522Pending
  • Ventricular Drain Or Shunt Asssembly With Recording ElectrodeApplication PCTUS2022054049Pending
  • Implantable Cranial Medical DeviceApplication 63421566Pending
  • Development And Implementation Of Psychological State ModelApplication PCTUS2022047860Pending
  • Implantable Medical Device And SystemApplication 63342420Pending
  • Implantable Medical Device For Use With Or Having Recording ElectrodeApplication 63310288Pending
  • Ventricular Drain Or Shunt Asssembly With Recording ElectrodeApplication 63294611Pending
  • Development And Implementation Of Psychological State ModelApplication 63280367Pending
  • Fluid Catheter Device For Recording Brain StateApplication PCTUS2021042315Pending
  • Monitoring Based On Continuous Intracranial Eeg ActivityApplication PCTUS2021042351Pending
  • Medical Device Having Non-filtered Csf Withdrawal PathwayApplication PCTUS2021041772Pending
  • Implantable Cranial Medical DeviceApplication PCTUS2021041763Pending
  • Implantable Cranial Medical DeviceApplication PCTUS2023036432Pending
  • Implantable Cranial Medical DeviceApplication 63209835Pending
  • Monitoring And Treatment Based On Continuous Intracranial Eeg ActivityApplication 63054522Pending
  • Fluid Catheter Device For Recording Brain StateApplication 63053864Pending
  • Implantable Cranial Medical DeviceApplication 63052284Pending
  • Infusing Drug Solution Directly Into Brain FluidApplication PCTUS2019068592Pending
  • Syringe For Delivering Medications To Implanted Drug Delivery Systems And Methods For Use ThereofApplication PCTUS2018057146Pending
  • Treatment And Monitoring Of Diseases Associated With Elevated Intracranial Pressure Or HydrocephalusApplication 63223629Pending
  • High Concentration Medicant Solutions For Treating Neurological DisordersApplication PCTUS2018057150Pending
  • Syringe For Delivering Medications To Implanted Drug Delivery Systems And Methods For Use ThereofApplication 62575767Pending
  • High Concentration Medicant Solutions For Treating Neurological DisordersApplication 62575770Pending
  • Direct Brain Administration Of Chemotherapeutics To The Csf For Patients With Primary And Secondary Brain TumorsApplication PCTUS2017050217Pending
  • Implantable Intraventricular Sampling And Infusion Access DeviceApplication PCTUS2017044452Pending
  • Medical System Including Two Access PortsApplication PCTUS2021041766Pending
  • Implantable Medical Device And SystemApplication PCTUS2023021974Pending
  • Implantable Cranial Medical DeviceApplication 63455335Pending
  • Implantable Medical Device For Use With Or Having Recording ElectrodeApplication PCTUS2023012940Pending
  • NEXGENIA, INC.Similar federal contract value in Biotech · null in contracts
  • Terremoto BiosciencesSimilar federal contract value in Biotech · null in contracts
  • NephroDI Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
  • Lindy Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
  • NewcelX Ltd.Similar federal contract value in Biotech · null in contracts
  • HCW Biologics Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .